Vitality Watch

Dossier pubmed review 03-aug-2026
Narrative review or expert overview without new data

Aging at the neurovascular interface: An integrative framework linking cardiovascular and cerebrovascular diseases.

Key claim: Aging may disrupt a shared neurovascular interface (NVI) in heart and brain—via vascular, neural, inflammatory, and extracellular-matrix changes, modified by genetic susceptibility—linking cardiovascular and cerebrovascular comorbidity, with lifestyle, senolytics, and gene-guided precision medicine as candidate strategies.

Abstract

Aging is a fundamental driver of cardiovascular and cerebrovascular comorbidities, yet the mechanisms linking aging to concurrent heart and brain diseases remain incompletely understood. The neurovascular interface (NVI) refers to the structural and functional interface through which neural, vascular, and extracellular-matrix signals interact. In the CNS, this concept substantially overlaps with the classical neurovascular unit, whereas in the heart it refers to an emerging heart tissue-specific interface involving coronary microvessels, vascular cells, autonomic and sensory nerve fibers, cardiomyocytes, and extracellular-matrix components. Although direct experimental evidence that aging affects cardiovascular and cerebrovascular comorbidity through NVI is still accumulating, current evidence suggests that aging may disrupt shared neurovascular features. These changes are associated with hypertension, cerebral small vessel disease, heart failure, and related disorders. Moreover, genetic variants may act as susceptibility modifiers of neurovascular aging - from NOS3 regulating vascular tone to ADRB1 and COMT affecting autonomic balance. These variants are associated with cardiovascular and cerebrovascular disease risk and may represent upstream molecular determinants through which genetic susceptibility and aging-related stressors converge to alter NVI integrity and promote cardiovascular-cerebrovascular comorbidity. This review synthesizes current evidence on the structural and functional basis of the NVI, discusses how aging may disrupt its integrity, and evaluates its potential role as an integrative framework linking aging-related vascular, neural, inflammatory, and extracellular-matrix alterations to cardiovascular-cerebrovascular comorbidity. We also outline potential integrated strategies that may preserve interface function, including lifestyle interventions, senolytics, and gene-guided precision medicine.

Why this matters

The NVI framing proposes that heart and brain share a mechanistically overlapping neurovascular interface whose age-related decline (vascular + neural + inflammatory + ECM, gated by genetics) underlies their well-known clinical comorbidity, giving mechanism pages a common substrate to hang cardio-cerebrovascular findings on rather than treating them as separate organ silos. It also foregrounds a gap worth tracking: the pitch already reaches for senolytics and ‘precision’ gene-guided therapies while the underlying NVI concept is still a hypothesis-level synthesis with no interventional human validation.

Source

Link

Briefing card

Aging at the neurovascular interface: An integrative framework linking cardiovascular and cerebrovascular diseases.
Stage: review · pubmed · 03-aug-2026

Aging may disrupt a shared neurovascular interface (NVI) in heart and brain—via vascular, neural, inflammatory, and extracellular-matrix changes, modified by genetic susceptibility—linking cardiovascular and cerebrovascular comorbidity, with lifestyle, senolytics, and gene-guided precision medicine as candidate strategies.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1016/j.arr.2026.103285

build build 880 · 2bcef25 · 2026-11-18